Navigation Links
ValGenesis, Inc. Announces Worldwide Release of Validation Life Cycle Management System - ValGenesis 2.0

FREMONT, Calif., June 26 /PRNewswire/ -- ValGenesis, Inc., a leading provider of Enterprise Validation Management software solutions, announced the worldwide availability of ValGenesis 2.0, the latest version of its breakthrough Web-based, multi-site, scalable validation life cycle management and automation product.

Life science companies implementing the ValGenesis software suite can efficiently manage the entire validation life cycle and move securely from manual, paper-based validation processes to a 100 percent paperless, fully electronic validation process. ValGenesis enforces consistency and enhances compliance in the corporate validation process. Users see a holistic view of a company's validation status and are able to identify bottlenecks, reducing validation cycle time and cost by 40 to 50 percent.

An out-of-the-box solution, with template-driven rapid implementation methodology requiring less overall implementation and validation time, this allows ValGenesis clients' Information Technology and Validation personnel to easily manage other projects in parallel. Among the enhancements in ValGenesis 2.0 are improved requirements management, expanded traceability matrix capability, risk assessment, offline validation execution, workflow design and collaboration through the robust library module.

ValGenesis 2.0 features the ability to implement a single validation system for all corporate/site validation requirements. A centralized deployment provides easier maintenance. By providing 360-degree visibility to the validation process, communication among all cross-functional users is significantly enhanced, while internal and external audit preparation time is reduced by 90 percent. End-users can easily personalize the web-based interface to their needs and interest.

"ValGenesis 2.0 includes substantial technological advancements, enhances the team-based review and can be hosted at a single location and deployed globally in order to address our customers' increasing need for collaboration in today's stringently regulated marketplace," said Siva Samy, PhD, ValGenesis Chief Product Strategist. "We have incorporated several new features and enhancements based on recommendations from our customers which allow our new customers to fully address their core validation requirements and expedite the validation process while remaining fully compliant with industry regulations." He added, "This version introduces the first phase of our new integration initiative. We've partnered with leading companies in the content management and ERP sectors to provide fully integrated solutions." Samy said, "We are particularly excited about the potential for significant savings to our clients using this version's global validation capabilities in which reviewers, approvers and engineers (developers and testers) can share and review information from different locations simultaneously."

About ValGenesis

ValGenesis offers an innovative software platform that serves as the foundation for compliance-based validation life cycle management in regulated companies. ValGenesis is the first Enterprise application to automate the validation life cycle of GxP systems and to provide 360-degree visibility to the corporate validation process. ValGenesis is designed to fully conform to FDA 21 CFR Part 11 compliance requirements. Through an industry peer review committee, the Parenteral Drug Association (PDA) awarded ValGenesis the prestigious New Innovative Technology award.

For more information, visit ValGenesis's web site at

Press Contact:

Mike Beaudro

Marketing Manager

Ph: 510 445 0505

This release was issued through eReleases(TM). For more information, visit

SOURCE ValGenesis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
(Date:11/24/2015)... Worcester, Mass. (PRWEB) , ... November 24, 2015 ... ... need to maintain healthy metabolism. But unless it is bound to proteins, copper ... Institutes of Health (NIH), researchers at Worcester Polytechnic Institute (WPI) will conduct a ...
(Date:11/24/2015)... RALEIGH, N.C. , Nov. 24, 2015  Clintrax Global, Inc., ... Raleigh, North Carolina , today announced that the company has ... earnings represented a 391% quarter on quarter growth posted for Q3 ... Kingdom and Mexico , with the ... place in December 2015. --> United Kingdom ...
(Date:11/24/2015)... Muncie, IN (PRWEB) , ... November 24, 2015 , ... ... its newest Special Interest Group (SIG), MultiGP, also known as Multirotor Grand Prix, to ... in the last few years. Many AMA members have embraced this type of racing ...
(Date:11/24/2015)... 24, 2015  Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced that its ... at 11:00 a.m. Israel time, at the law ... Allon Street, 36 th Floor, Tel Aviv, Israel ... and Izhak Tamir to the Board of Directors; ... directors; , approval of an amendment to certain terms of options ...
Breaking Biology Technology:
(Date:11/17/2015)... LIVERMORE, Calif. , Nov. 17, 2015  Vigilant ... has joined its Board of Directors. ... Vigilant,s Board after recently retiring from the partnership at ... owning 107 companies with over $140 Billion in revenue.  ... performance improvement across all the TPG companies, from 1997 ...
(Date:11/12/2015)... -- A golden retriever that stayed healthy despite having the ... a new lead for treating this muscle-wasting disorder, report ... MIT and Harvard and the University of São Paolo ... Cell, pinpoints a protective gene that boosts muscle ... Boston Children,s lab of Lou Kunkel , PhD, ...
(Date:11/11/2015)... MedNet Solutions , an innovative SaaS-based eClinical technology company that ... announce that it will be a Sponsor of the ... held November 17-19 in Hamburg , Germany.  ... iMedNet , MedNet,s easy-to-use, proven and affordable eClinical ... able to deliver time and cost savings of up to ...
Breaking Biology News(10 mins):